ORCHID PHARMA Share Price

Orchid Pharma Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of formulations and active pharmaceutical ingredients (API). It operates through the pharmaceutical segment. It has a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardiovascular segment (CVS), nutraceuticals and other oral and sterile products. Its pharmaceutical solutions include active pharmaceutical ingredients (APIs) and finished dosage forms. It offers APIs, including Cephalosporins-Orals, Cephalosporins-Injectables, and Veterinary Products. Its formulations include Cefixime Capsules, Acarbose Tablets, Clozapime Tablets, Clopidogrel Tablets, Desloratadine Tablets and Cefoperazone and Sulbactam for Injection, among others. Its subsidiaries include Orchid Bio-Pharma Limited, Orchid Pharmaceuticals Inc., Bexel Pharmaceuticals Inc. and Diakron Pharmaceuticals, Inc.As of 25 May 2026, ORCHID PHARMA share price is ₹715.35. The stock opened at ₹712.05, compared to its previous close of ₹706.50. During today's trading session, ORCHID PHARMA share price moved in the range of ₹692.05 to ₹722.90, with an average price of ₹707.47 for the day. Looking at its last 52-week, the stock has touched a low of ₹692.05 and a high of ₹722.90. On the performance front, ORCHID PHARMA share price has declined by 18.46% over the last six months and is down 2.23% on a year-on-year basis.

The market capitalization of ORCHID PHARMA is ₹3,591 Crs, with a P/E ratio of 190.3 and a dividend yield of 0.00%.